Cardiff Lexington Corporation (CDIX)
OTCMKTS
· Delayed Price · Currency is USD
3.818
-0.183 (-4.56%)
Mar 6, 2026, 3:51 PM EST
Cardiff Lexington Revenue
Cardiff Lexington had revenue of $3.06M in the quarter ending September 30, 2025, with 125.63% growth. This brings the company's revenue in the last twelve months to $11.88M, up 57.91% year-over-year. In the year 2024, Cardiff Lexington had annual revenue of $8.27M, down -30.23%.
Revenue (ttm)
11.88M
Revenue Growth
+57.91%
P/S Ratio
4.22
Revenue / Employee
742.75K
Employees
17
Market Cap
50.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.27M | -3.58M | -30.23% |
| Dec 31, 2023 | 11.85M | 1.16M | 10.85% |
| Dec 31, 2022 | 10.69M | 814.14K | 8.24% |
| Dec 31, 2021 | 9.88M | 6.43M | 186.10% |
| Dec 31, 2020 | 3.45M | -254.30K | -6.86% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Comjoyful International Company | 564.97K |
| Mid-Atlantic Home Health Network | 27.00M |
| HealthLynked | 2.37M |
| Selectis Health | 42.17M |
| American Oncology Network | 1.76B |
| BioCorRx | 948.36K |
| Xcelerate | 2.70M |
| Univec | 28.63K |